Michael F. Mahoney – President and Chief Executive Officer of Boston Scientific Corporation – Email Address

Michael Mahoney is President and Chief Executive Officer of Boston Scientific Corporation and a member of the company’s board of directors. Mahoney oversees global development, marketing and sales of the company’s broad medical solutions portfolio. He assumed this role in November 2012, after serving one year as president of Boston Scientific, leading the Cardiac Rhythm Management (CRM) and Endoscopy (GI and Pulmonary) business divisions. Mahoney joined the company in October 2011, with a 24-year track record of building market-leading medical device, capital equipment and healthcare IT businesses.

Prior to Boston Scientific, Mahoney served as Worldwide Chairman of Johnson Johnson’s Medical Devices and Diagnostics (MDD) division, overseeing seven franchises and 50,000 employees. He previously served as Worldwide Group Chairman of Johnson Johnson’s DePuy orthopedics and neuro-sciences business, where he drove growth through product innovation, acquisitions and market expansion into China and India.

Mahoney was President and Chief Executive Officer of Global Healthcare Exchange (GHX), a leading supply chain solutions company. He built GHX through organic development, seven strategic acquisitions and expanding into Canada and Europe. For the first 12 years of Mahoney’s career, he advanced through a series of leadership roles at General Electric Medical Systems, reaching the position of General Manager of the company’s Healthcare Information Technology business.

Mahoney serves on AdvaMed's board of directors and is a member of the American Heart Association CEO Roundtable. He earned a B.B.A. in Finance from the University of Iowa and his M.B.A. from Wake Forest University. Mike is married and has three children.

The Boston Scientific Corporation (abbreviated BSC) is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a range of interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.

Boston Scientific is well known for the development of the Taxus Stent, a drug-eluting stent which is used to open clogged arteries.[3]

Boston Scientific's main competitors are Johnson and Johnson, Medtronic, St. Jude Medical, and the Abbott Vascular division of Abbott Laboratories.[citation needed]

Comments are closed.